BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 18639746)

  • 1. Abundant expression of zinc transporters in the amyloid plaques of Alzheimer's disease brain.
    Zhang LH; Wang X; Stoltenberg M; Danscher G; Huang L; Wang ZY
    Brain Res Bull; 2008 Sep; 77(1):55-60. PubMed ID: 18639746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High sensitivity analysis of amyloid-beta peptide composition in amyloid deposits from human and PS2APP mouse brain.
    Güntert A; Döbeli H; Bohrmann B
    Neuroscience; 2006 Dec; 143(2):461-75. PubMed ID: 17008022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. UV light-induced autofluorescence of full-length Abeta-protein deposits in the human brain.
    Thal DR; Ghebremedhin E; Haass C; Schultz C
    Clin Neuropathol; 2002; 21(1):35-40. PubMed ID: 11846043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apolipoprotein D is a component of compact but not diffuse amyloid-beta plaques in Alzheimer's disease temporal cortex.
    Desai PP; Ikonomovic MD; Abrahamson EE; Hamilton RL; Isanski BA; Hope CE; Klunk WE; DeKosky ST; Kamboh MI
    Neurobiol Dis; 2005 Nov; 20(2):574-82. PubMed ID: 15916898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding of two potential imaging agents targeting amyloid plaques in postmortem brain tissues of patients with Alzheimer's disease.
    Kung MP; Hou C; Zhuang ZP; Skovronsky D; Kung HF
    Brain Res; 2004 Oct; 1025(1-2):98-105. PubMed ID: 15464749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The possible role of capillary cerebral amyloid angiopathy in Alzheimer lesion development: a regional comparison.
    Jeynes B; Provias J
    Acta Neuropathol; 2006 Oct; 112(4):417-27. PubMed ID: 16830133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deposition of monomeric, not oligomeric, Abeta mediates growth of Alzheimer's disease amyloid plaques in human brain preparations.
    Tseng BP; Esler WP; Clish CB; Stimson ER; Ghilardi JR; Vinters HV; Mantyh PW; Lee JP; Maggio JE
    Biochemistry; 1999 Aug; 38(32):10424-31. PubMed ID: 10441137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relative paucity of tau accumulation in the small areas with abundant Abeta42-positive capillary amyloid angiopathy within a given cortical region in the brain of patients with Alzheimer pathology.
    Oshima K; Akiyama H; Tsuchiya K; Kondo H; Haga C; Shimomura Y; Iseki E; Uchikado H; Kato M; Niizato K; Arai H
    Acta Neuropathol; 2006 Jun; 111(6):510-8. PubMed ID: 16718347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regression stage senile plaques in the natural course of Alzheimer's disease.
    Oide T; Kinoshita T; Arima K
    Neuropathol Appl Neurobiol; 2006 Oct; 32(5):539-56. PubMed ID: 16972888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metal binding and oxidation of amyloid-beta within isolated senile plaque cores: Raman microscopic evidence.
    Dong J; Atwood CS; Anderson VE; Siedlak SL; Smith MA; Perry G; Carey PR
    Biochemistry; 2003 Mar; 42(10):2768-73. PubMed ID: 12627941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isoaspartate formation at position 23 of amyloid beta peptide enhanced fibril formation and deposited onto senile plaques and vascular amyloids in Alzheimer's disease.
    Shimizu T; Fukuda H; Murayama S; Izumiyama N; Shirasawa T
    J Neurosci Res; 2002 Nov; 70(3):451-61. PubMed ID: 12391606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. alpha-Internexin immunoreactivity reflects variable neuronal vulnerability in Alzheimer's disease and supports the role of the beta-amyloid plaques in inducing neuronal injury.
    Dickson TC; Chuckowree JA; Chuah MI; West AK; Vickers JC
    Neurobiol Dis; 2005 Mar; 18(2):286-95. PubMed ID: 15686957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intraneuronal Abeta accumulation and origin of plaques in Alzheimer's disease.
    Gouras GK; Almeida CG; Takahashi RH
    Neurobiol Aging; 2005 Oct; 26(9):1235-44. PubMed ID: 16023263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain site-specific gene expression analysis in Alzheimer's disease patients.
    Yokota T; Mishra M; Akatsu H; Tani Y; Miyauchi T; Yamamoto T; Kosaka K; Nagai Y; Sawada T; Heese K
    Eur J Clin Invest; 2006 Nov; 36(11):820-30. PubMed ID: 17032350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated cortical zinc in Alzheimer disease.
    Religa D; Strozyk D; Cherny RA; Volitakis I; Haroutunian V; Winblad B; Naslund J; Bush AI
    Neurology; 2006 Jul; 67(1):69-75. PubMed ID: 16832080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of immunohistochemical and silver staining methods for the detection of diffuse plaques in the aged canine brain.
    Czasch S; Paul S; Baumgärtner W
    Neurobiol Aging; 2006 Feb; 27(2):293-305. PubMed ID: 16002188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble Abeta oligomers ultrastructurally localize to cell processes and might be related to synaptic dysfunction in Alzheimer's disease brain.
    Kokubo H; Kayed R; Glabe CG; Yamaguchi H
    Brain Res; 2005 Jan; 1031(2):222-8. PubMed ID: 15649447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel 'inflammatory plaque' pathology in presenilin-1 Alzheimer's disease.
    Shepherd CE; Gregory GC; Vickers JC; Halliday GM
    Neuropathol Appl Neurobiol; 2005 Oct; 31(5):503-11. PubMed ID: 16150121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Co-accumulation of vascular endothelial growth factor with beta-amyloid in the brain of patients with Alzheimer's disease.
    Yang SP; Bae DG; Kang HJ; Gwag BJ; Gho YS; Chae CB
    Neurobiol Aging; 2004 Mar; 25(3):283-90. PubMed ID: 15123332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absence of synaptophysin near cortical neurons containing oligomer Abeta in Alzheimer's disease brain.
    Ishibashi K; Tomiyama T; Nishitsuji K; Hara M; Mori H
    J Neurosci Res; 2006 Aug; 84(3):632-6. PubMed ID: 16721760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.